Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.99 USD | +0.97% | +4.88% | -8.60% |
May. 07 | DA Davidson Adjusts Price Target on USANA Health Sciences to $46 From $48, Maintains Neutral Rating | MT |
May. 01 | Transcript : USANA Health Sciences, Inc., Q1 2024 Earnings Call, May 01, 2024 |
Evolution of the average Target Price on USANA Health Sciences, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering USANA Health Sciences, Inc.
DA Davidson | |
Jefferies & Co. | |
Tigress Financial | |
Roth Capital Partners |
EPS Revisions
- Stock Market
- Equities
- USNA Stock
- Consensus USANA Health Sciences, Inc.